EvideraLondon, England, United Kingdom
I do not have any relevant financial / non-financial relationships with any proprietary interests.
1584 - CARISEL A Hybrid III Implementation Effectiveness Study of implementation of Cabotegravir plus Rilpivirine Long Acting (CAB+RPV LA) in EU Health Care Settings Key Clinical and Implementation Outcomes by Implementation Arm
Friday, October 21, 20223:45 PM - 4:00 PM US ET